Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma

Oral Oncology

Volumn 41, Issue 3, 2005, Pages 276-282

  Obara, Seiji ^a   Yamamoto, Kazumi ^a   Hosogai, Nao ^a   Yoshimura, Yasuro ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Chemosensitivity; Dihydropyrimidine dehydrogenase; Immunohistochemistry; Oral squamous cell carcinoma; Thymidylate synthase; TS 1

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDYLATE SYNTHASE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; KIDNEY DISEASE; LEUKOPENIA; LIVER DYSFUNCTION; MALE; MOUTH CARCINOMA; NAUSEA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 14644415548     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.08.016     Document Type: Article

References (21)

1. T. Shirasaka, K. Nakano, T. Takechi, H. Satake, J. Uchida, and A. Fujioka Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyrimidine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 1996 2602 2606
2. T. Shirasaka, Y. Shimamoto, H. Ohshino, M. Yamaguchi, T. Kato, and K. Yonekura Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 1995 548 557
3. S. Miyamoto, N. Boku, A. Ohtsu, S. Yoshida, A. Ochiai, and H. Okabe Clinical implication of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1) Int J Oncol 17 2000 653 658
4. M.C. Etienne, S. Cheradme, J.L. Fischel, P. Formento, O. Dassonville, and N. Renee Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity J Clin Oncol 13 1995 1663 1670
5. M. Inokuchi, H. Uetake, Y. Shirota, H. Yamada, M. Tajima, and K. Sugihara Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis Cancer Chemother Phrmacol 53 2004 391 396
6. T. Ma, Z.-G. Zhu, Y.-B. Ji, Y. Zhang, Y.-Y. Yu, and B.-Y. Liu Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2′-deoxyuridine World J Gastroenterol 10 2004 172 176
7. S. Popat, A. Matakidou, and R.S. Houlston Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis J Clin Oncol 22 2004 529 536
8. H. Miyamoto, A. Morio, H. Izumi, A. Yamazaki, Z. Wang, and T. Futagawa Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer Anticancer Res 23 2003 4153 4156
9. G. Kawasaki, I. Yoshitomi, S. Yamamoto, and A. Mizuno Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: An immunohistochemical and clinicopathologic study Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 2002 717 723
10. K. Kawano, H. Goto, T. Kanda, and S. Yanagisawa Predictive value of immunohistochemical thymidylate synthase expression for histological response tegafur/uracil (UFT) in oral squamous cell carcinoma Int J Oral Maxillofac Surg 32 2003 633 637
11. M.O. Hoque, H. Kawamata, K.I. Nakashiro, F. Omotehara, Y. Shinagawa, and S. Hino Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer Int J Oncol 19 2001 953 958
12. K. Omura Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutation the DPD gene, and DPD inhibitory fluoropyrimidines Int J Clin Oncol 8 2003 132 138
13. Y. Nio, M. Italura, M. Koike, H. Omori, K. Hashimoto, and S. Yano A self-expandable metallic stent in combination with cholangioscopic against obstructive jaundice due to recurrent gastric cancer: a case report of successful treatment Anticancer Res 23 2003 1795 1801
14. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO; 1979. p. 15-22
15. Y. Suzuki, Y. Ishibiki, K. Kawai, M. Sasaki, M. Matsuda, and T. Watanabe Effect of combination of TS-1 and low-dose cisplatin on sarcoma-180 mouse sarcoma Anticancer Drugs 14 2003 475 479
16. R. Corvo, I. Pastrone, T. Scolaro, M. Marcenaro, L. Berretta, and S. Chiara Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives Tumori 89 2003 361 367
17. H. Iguchi, K. Hashimoto, K. Sunami, M. Takayama, A. Nakamura, and H. Yamane A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1 Gan To Kagaku Ryoho 30 2003 101 104
18. C.J. Johnston, J.C. Drake, J. Trepel, and C.J. Allegra Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and resistant human cancer cell lines Cancer Res 50 1992 4306 4312
19. S. Romain, P.O. Bendahl, O. Guirou, P. Malmstrom, P.M. Martin, and M. Ferno DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopsusal patients Int J Cancer 95 2001 56 61
20. T. Nakagawa, Y. Otake, K. Yanagihara, R. Miyahara, S. Ishikawa, and F. Masakazu Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC) Lung Cancer 43 2004 145 149
21. T. Nomura, M. Nakagawa, Y. Fujita, T. Hanada, H. Miyata, and Y. Nomura Clinical significance of thymidylate synthase expression in bladder cancer Int J Urol 9 2002 368 376